Cite
HARVARD Citation
Yan, Y. et al. (2018). Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer. EMBO molecular medicine. 10 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yan, Y. et al. (2018). Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer. EMBO molecular medicine. 10 (4), p. n/a. [Online].